Warnings, analyses, and recommendations for serotonin reuptake inhibitors in patients under 18 years of age;Serotoninwiederaufnahmehemmer im kindes- und jugendalter: Warnhinweise der behörden, analyseergebnisse und empfehlungen

Nervenarzt

Volumn 76, Issue 11, 2005, Pages 1330-1339

  Fegert, J M ^a   Herpertz Dahlmann, B ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Depression in children and adolescents; Health care regulatory authorities; Serotonin reuptake inhibitors; Suicidality

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL PRACTICE; COGNITIVE THERAPY; DEPRESSION; DRUG CONTRAINDICATION; DRUG CONTROL; DRUG INDICATION; GROUPS BY AGE; HEALTH CARE; HEALTH SERVICE; HUMAN; PSYCHOPHARMACOLOGY; REVIEW; RISK; RISK REDUCTION; SUICIDE ATTEMPT;

CHILD; CHILD, PRESCHOOL; DEPRESSIVE DISORDER; EUROPE; GERMANY; HUMANS; PRACTICE GUIDELINES; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 28744433187     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-1969-7     Document Type: Review

References (25)

1. Barbarich NC, McConaha CW, Gaskill J et al. (2004) An open trial of olanzapine in anorexia nervosa. J Clin Psychiatry 65:1480-1482
2. Birmaher B, Williamson DE, Dahl RE et al. (2004) Clinical presentation and course of depression in youth: does onset in childhood differ from onset in adolescence? J Am Acad Child Adolesc Psychiatry 43:63-70
3. Brent DA (2004) Antidepressants and pediatric depression - the risk of doing nothing. N Engl J Med 351:1598-1601
4. Fegert JM (2003) Ethical and legal problems in treating schizophrenic patients with neuroleptics during childhood and adolescence. Child Adolesc Psychopharmacol News 8:5-9
5. Fegert JM (2004) Depressionsbehandlung mit SSRI in der Kinder- und Jugend psychiatrie - Ein Forschungs- oder ein Informationsdebakel? Nervenheilkunde 23:60-64
6. Fegert JM, Herpertz-Dahlmann B (2004) Zum Einsatz von selektiven Serotoninwiederaufnahmehemmern (SSRI) bei depressiven Kindern und Jugendlichen. Z Kinder Jugendpsychiatr Psychother 32:74-75
7. Ferguson CP, La Via MC, Crossan PJ et al. (1999) Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa. Int J Eat Disord 25:11-17
8. Halmi KA, Eckert ED, La Du TJ et al. (1986) Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 43:177-181
9. Hazell P, O'Connell D, Heathcote D et al. (2003) Tricyclic drugs for depression in children and adolescents (Cochrane Review). The Cochrane Library (4)
10. Holtkamp K, Konrad K, Kaiser N et al. (2005) A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res 39:303-310
11. Holtmann M, Bölte S, Poustka F (2005) Suizidalität bei depressiven Kindern und Jugendlichen unter Behandlung mit Selektiven Serotonin-Wiederaufnahmehemmern (SSRI). Dtsch Ärzteblatt (im Druck)
12. Holtmann M, Bölte S, Wöckel L et al. (2005) Antidepressive Therapie bei Kindern und Jugendlichen. Dtsch Ärztebl 14:822-824
13. Kaufman J, Martin A, King RA et al. (2001) Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry 49:980-1001
14. Khan RS, Khoury J, Nichols WC et al. (2003) Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive and oppositional behaviors. J Pediatr 143:104-110
15. Meltzer H, Gatward R, Goodman R et al. (2000) The mental health of children and adolescents in Great Britain. The Stationery Office, London
16. MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: the MTA cooperative group multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56:1073-1086
17. Mufson L, Dorta KP, Wickramaratne P et al. (2004) A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 61:577-584
18. Newman TB (2004) A black-box warning for antidepressants in children? N Engl J Med 351:1595-1598
19. Olfson M, Marcus SC, Greenberg T (2003) Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978-982
20. Silber JL, Rutter M, Neale M et al. (2001) Genetic moderation of environmental risk for depression and anxiety in adolescent girls. Br J Psychiatry 179:116-121
21. TADS-Study-Group (2004) The Treatment for Adolescents with Depression Study (TADS): short-term effectiveness and safety outcomes. JAMA 7:807-820
22. Whittington C, Kendall T, Fonagy P et al. (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341-1345
23. Whittington CJ, Kendall T, Pilling S (2005) Are the SSRIs and atypical antidepressants safe and effective for children and adolescents? Curr Opin Psychiatry 18:21-25
24. Zito JM, Derivan AT, Greenhill L (2004) Making research data available: an ethical imperative demonstrated by the SSRI debacle. J Am Acad Child Adolesc Psychiatry 43:512-514
25. Zito JM, Fegert JM, de Jong-van den Berg LTW et al. (2005) Verordnung von SSRIs für Kinder und Jugendliche im internationalen Vergleich: USA, Niederlande und Deutschland. In: Resch F (Hrsg) Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. XXIX. Kongress der Deutschen Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie. Die Abstracts. Vandenhoeck & Ruprecht, Göttingen